References
- Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissueresident immune cells in psoriasis. Trends Immunol. 2007;28(2):51-7. https://doi.org/10.1016/j.it.2006.12.005
- Korean Dermatology Association. Dermatology. 5th ed. Seoul:Ryo Moon Gak.P.Co. 2008:241.
- Youn JL. Psoriasis Clinic. Seoul:Designmeca. 2004:102.
- Youn JL. Etiology & Treatment of Psoriasis Update. Seoul:Designmeca. 2006:7-8.
- Kim NK, Hwang CY, Lim GS. The Oriental and Occidental bibliographic Study of Psoriasis. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 1999;12(1):154-76.
- Hong SH. Reviewing Research on Korean medical treatment of Psoriasis. The Journal of Korean Medical Ophthalmology & Otolaryngology & Dermatology. 2013;26(4):26-42. https://doi.org/10.6114/jkood.2013.26.4.026
- Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157:238-44. https://doi.org/10.1159/000250839
- Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-92. https://doi.org/10.2165/00128071-200506060-00005
- Weinstein GD, White GM. An approach to the treatment of moderate to severe psoriasis with rotational therapy. J Am Acad Dermatol. 1993;28(3):454-9. https://doi.org/10.1016/0190-9622(93)70067-4
- Kim SY, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC. A comparison of efficacy and adverse reactions between Methotrexate and Cyclosporin A. Korean J Dermatol. 2014;52(9):615-21.
- Bangert CA, Costner MI. Methotrexate in dermatology. Dermatologic Therapy. 2007;20:216-28. https://doi.org/10.1111/j.1529-8019.2007.00135.x
- Grossman RM, Chevert S, Abi-Rached J, Blanchet F, Dubertret L. Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol. 1996;132(6):623-9. https://doi.org/10.1001/archderm.1996.03890300039008
- Kalb RE, Fiorentino DF, Lebwohl MG, Toole J, Poulin Y, Cohen AD, et al. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol. 2015;151(9):961-69. https://doi.org/10.1001/jamadermatol.2015.0718
- Park YC, Park HM, Lee SD. Inducible Mechanisms for Hepatotoxicity caused by Traditional Korean medicines in a view of toxicology. J Korean Oriental Med. 2011;32(4):48-67.
- Lee E, Park BW, Hea GJ, Ko H. A study on the side effects and toxicity of herbal medicine. Korean J Orient Int Med. 2002;23(2):222-7.
- Lee SY, Cheong JO, Yang TK, Koo BH. The feasibility and safety of herbal medication on short strature. Korean J Orient Int Med. 2001;22(4):513-7.
- Park SU, Jung WS, Moon SK, Go CN, Cho KH, Kim YS, et al. Clinical trial to evaluate the efficacy and safety of Tongxinluo in high risk group of cardiovascular diseases. The Korean Journal of Joongpoong. 2005;6(1):25-32.
- Bae SH, Park SU, Kang CW, Hong SH. Safety of korean herbal medicine used with western medicine on liver function: prospective observational study. Korean J Orient Int Med. 2013;34(2):192-203.
- Lee SY, Kang HJ, Jung MY. Case report of efficacy and safety of long term medication of Oncheongeum-gamibang. Korean J Oriental Physiology & Pathology. 2013;27(2):268-72.
- Lee JS, Lee SD. Effects of Liver Function on Blood of Drug Users(Herbal and Western) in Koreans. Kor. J. Oriental Preventive Medical Society. 2004;8(1):59-74.
- Yang JI, Lee KH, Kim YS, Shin MK, Yoo JH, Chang GT. A report on liver function tests of 82 psoriasis patients taking herbal medication over 3 months. J Korean Oriental Med. 2012;33(3):95-104.
Cited by
- 건선 환자 101명의 6개월간의 한의학적 치료효과에 대한 후향적 연구 vol.30, pp.4, 2016, https://doi.org/10.6114/jkood.2017.30.4.142
- 아토피피부염 및 건선 환자 증례를 통한 상한론 백호탕 조문의 '면구(面垢)'에 대한 새로운 해석 vol.34, pp.1, 2016, https://doi.org/10.15188/kjopp.2020.02.34.1.45
- 장기간 한약복용이 부인과 환자의 간 및 신장기능에 미치는 영향: panel연구 - 복용 전과 후 3, 6개월 비교를 중심으로 - vol.41, pp.1, 2016, https://doi.org/10.13048/jkm.20006